Bayesian methods for expression-based integration of various types of genomics data

por Jennings, Elizabeth M, Morris, Jeffrey S, Carroll, Raymond J, Manyam, Ganiraju C, Baladandayuthapani, Veerabhadran
Publicado 2013

Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis

por Jinesh, Goodwin G., Manyam, Ganiraju C., Mmeje, Chinedu O., Baggerly, Keith A., Kamat, Ashish M.
Publicado 2017

The deubiquitinase Otub1 controls the activation of CD8 T cells and NK cells by regulating IL-15-mediated priming

por Zhou, Xiaofei, Yu, Jiayi, Cheng, Xuhong, Zhao, Baoyu, Manyam, Ganiraju C, Zhang, Li, Schluns, Kimberly, Li, Pingwei, Wang, Jing, Sun, Shao-Cong
Publicado 2019

FuncPEP: A Database of Functional Peptides Encoded by Non-Coding RNAs

por Dragomir, Mihnea P., Manyam, Ganiraju C., Ott, Leonie Florence, Berland, Léa, Knutsen, Erik, Ivan, Cristina, Lipovich, Leonard, Broom, Bradley M., Calin, George A.
Publicado 2020

Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia

por Aslan, Burcu, Kismali, Gorkem, Iles, Lakesla R., Manyam, Ganiraju C., Ayres, Mary L., Chen, Lisa S., Gagea, Mihai, Bertilaccio, Maria Teresa Sabrina, Wierda, William G., Gandhi, Varsha
Publicado 2022

Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma

por Pham, Lan V., Bryant, Jerry L., Mendez, Richard, Chen, Juan, Tamayo, Archito T., Xu, Zijun Y., Young, Ken H., Manyam, Ganiraju C., Yang, David, Medeiros, L. Jeffrey, Ford, Richard J.
Publicado 2016

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up

por Zhou, Hui, Xu-Monette, Zijun Y., Xiao, Ling, Strati, Paolo, Hagemeister, Fredrick B., He, Yizi, Chen, Huan, Li, Yajun, Manyam, Ganiraju C., Li, Yong, Montes-Moreno, Santiago, Piris, Miguel A., Young, Ken H.
Publicado 2020

ATR Inhibition Induces CDK1–SPOP Signaling and Enhances Anti–PD-L1 Cytotoxicity in Prostate Cancer

por Tang, Zhe, Pilié, Patrick G., Geng, Chuandong, Manyam, Ganiraju C., Yang, Guang, Park, Sanghee, Wang, Daoqi, Peng, Shan, Wu, Cheng, Peng, Guang, Yap, Timothy A., Corn, Paul G., Broom, Bradley M., Thompson, Timothy C.
Publicado 2021

MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon

por Raghav, Kanwal, Morris, Van, Tang, Chad, Morelli, Pia, Amin, Hesham M., Chen, Ken, Manyam, Ganiraju C., Broom, Bradley, Overman, Michael J., Shaw, Kenna, Meric-Bernstam, Funda, Maru, Dipen, Menter, David, Ellis, Lee M., Eng, Cathy, Hong, David, Kopetz, Scott
Publicado 2016

PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in Prostate Cancer

por Wu, Cheng, Peng, Shan, Pilié, Patrick G., Geng, Chuandong, Park, Sanghee, Manyam, Ganiraju C., Lu, Yungang, Yang, Guang, Tang, Zhe, Kondraganti, Shakuntala, Wang, Daoqi, Hudgens, Courtney W., Ledesma, Debora A., Marques-Piubelli, Mario L., Torres-Cabala, Carlos A., Curry, Jonathan L., Troncoso, Patricia, Corn, Paul G., Broom, Bradley M., Thompson, Timothy C.
Publicado 2021

Lentiviral interferon: A novel method for gene therapy in bladder cancer

por Mokkapati, Sharada, Narayan, Vikram M., Manyam, Ganiraju C., Lim, Amy H., Duplisea, Jonathan J., Kokorovic, Andrea, Miest, Tanner S., Mitra, Anirban P., Plote, Devin, Anand, Selvalakshmi Selvaraj, Metcalfe, Michael J., Dunner, Kenneth, Johnson, Burles A., Czerniak, Bogdan A., Nieminen, Tiina, Heikura, Tommi, Yla-Herttuala, Seppo, Parker, Nigel R., Schluns, Kimberley S., McConkey, David J., Dinney, Colin P.
Publicado 2022

EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer

por Wang, Xiaoping, Semba, Takashi, Manyam, Ganiraju C., Wang, Jing, Shao, Shan, Bertucci, Francois, Finetti, Pascal, Krishnamurthy, Savitri, Phi, Lan Thi Hanh, Pearson, Troy, Van Laere, Steven J., Burks, Jared K., Cohen, Evan N., Reuben, James M., Yang, Fei, Min, Hu, Navin, Nicholas, Trinh, Van Ngu, Iwase, Toshiaki, Batra, Harsh, Shen, Yichao, Zhang, Xiang, Tripathy, Debu, Ueno, Naoto T.
Publicado 2022

Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma

por Ye, Qing, Xu-Monette, Zijun Y., Tzankov, Alexandar, Deng, Lijuan, Wang, Xiaoxiao, Manyam, Ganiraju C., Visco, Carlo, Montes-Moreno, Santiago, Zhang, Li, Dybkær, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Parsons, Ben M., Møller, Michael B., Piris, Miguel A., Winter, Jane N., Medeiros, L. Jeffrey, Hu, Shimin, Young, Ken H.
Publicado 2015

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma

por Zhang, Mingzhi, Xu-Monette, Zijun Y., Li, Ling, Manyam, Ganiraju C., Visco, Carlo, Tzankov, Alexandar, Wang, Jing, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., Han van Krieken, J., Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Jeffrey Medeiros, L., Pham, Lan V., Young, Ken H.
Publicado 2016

Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies

por Xu-Monette, Zijun Y., Li, Jianyong, Xia, Yi, Crossley, Beryl, Bremel, Robert D., Miao, Yi, Xiao, Min, Snyder, Thomas, Manyam, Ganiraju C., Tan, Xiaohong, Zhang, Hongwei, Visco, Carlo, Tzankov, Alexandar, Dybkaer, Karen, Bhagat, Govind, Tam, Wayne, You, Hua, Hsi, Eric D., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J. M., Møller, Michael B., Piris, Miguel A., Winter, Jane N., Medeiros, Jeffrey T., Xu, Bing, Li, Yong, Kirsch, Ilan, Young, Ken H.
Publicado 2019

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

por Chen, Jiayu, Xu-Monette, Zijun Y., Deng, Lijuan, Shen, Qi, Manyam, Ganiraju C., Martinez-Lopez, Azahara, Zhang, Li, Montes-Moreno, Santiago, Visco, Carlo, Tzankov, Alexandar, Yin, Lihui, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhao, Xiaoying, Møller, Michael B., Farnen, John P., Winter, Jane N., Piris, Miguel A., Pham, Lan, Young, Ken H.
Publicado 2015

Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma

por Li, Ling, Xu-Monette, Zijun Y., Ok, Chi Young, Tzankov, Alexandar, Manyam, Ganiraju C., Sun, Ruifan, Visco, Carlo, Zhang, Mingzhi, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Møller, Michael B., Wang, Jinfeng, Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Pham, Lan V., Medeiros, L. Jeffrey, Young, Ken H.
Publicado 2015

p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function

por Xu-Monette, Zijun Y., Zhang, Shanxiang, Li, Xin, Manyam, Ganiraju C., Wang, Xiao-xiao, Xia, Yi, Visco, Carlo, Tzankov, Alexandar, Zhang, Li, Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhao, Xiaoying, Møller, Michael B., Parsons, Ben M., Winter, Jane N., Piris, Miguel A., Medeiros, L. Jeffrey, Young, Ken H.
Publicado 2016

Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma–is it necessary?

por Ok, Chi Young, Ye, Qing, Li, Ling, Manyam, Ganiraju C., Deng, Lijuan, Goswami, Rashmi R., Wang, Xiaoxiao, Montes-Moreno, Santiago, Visco, Carlo, Tzankov, Alexandar, Dybkaer, Karen, Zhang, Li, Abramson, Jeremy, Sohani, Aliyah R., Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W.L., van Krieken, J. Han, Huh, Jooryung, Ponzoni, Maurilio, Ferreri, Andrés J.M., Zhang, Shanxiang, Parsons, Ben M., Xu, Mina, Møller, Michael B., Winter, Jane N., Piris, Miguel A., Xu-Monette, Zijun Y., Medeiros, L. Jeffrey, Young, Ken H.
Publicado 2015

The Consensus Molecular Subtypes of Colorectal Cancer

por Guinney, Justin, Dienstmann, Rodrigo, Wang, Xin, de Reyniès, Aurélien, Schlicker, Andreas, Soneson, Charlotte, Marisa, Laetitia, Roepman, Paul, Nyamundanda, Gift, Angelino, Paolo, Bot, Brian M., Morris, Jeffrey S., Simon, Iris M., Gerster, Sarah, Fessler, Evelyn, de Sousa e Melo, Felipe, Missiaglia, Edoardo, Ramay, Hena, Barras, David, Homicsko, Krisztian, Maru, Dipen, Manyam, Ganiraju C., Broom, Bradley, Boige, Valerie, Perez-Villamil, Beatriz, Laderas, Ted, Salazar, Ramon, Gray, Joe W., Hanahan, Douglas, Tabernero, Josep, Bernards, Rene, Friend, Stephen H., Laurent-Puig, Pierre, Medema, Jan Paul, Sadanandam, Anguraj, Wessels, Lodewyk, Delorenzi, Mauro, Kopetz, Scott, Vermeulen, Louis, Tejpar, Sabine
Publicado 2015